PIRAMAL PHARMA
Back to All Ratios
|
PIRAMAL PHARMA Last 5 Year EV/EBIT History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|
EV/EBIT(x) | 59.65 | 7.14 | 3.15 |
What is the latest EV/EBIT ratio of PIRAMAL PHARMA ?
Year | EV/EBIT |
---|---|
Mar2023 | 59.65 |
Mar2022 | 7.14 |
Mar2021 | 3.15 |
How is EV/EBIT of PIRAMAL PHARMA Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2023 | 59.65 | 735.43 | |
Mar2022 | 7.14 | 126.67 | |
Mar2021 | 3.15 | - |
Other Financial Ratios of PIRAMAL PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹19,836.9 Cr | 1.8% | 5.5% | 99.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹351,467.0 Cr | -4.8% | -3.5% | 59.7% | Stock Analytics | |
CIPLA | ₹119,470.0 Cr | 2.4% | 5.2% | 59.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹116,563.0 Cr | 5.9% | 10.8% | 21.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,690.0 Cr | -2.8% | 11.3% | 112.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,351.1 Cr | 1.8% | -5.4% | 31.5% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 1.8% |
5.5% |
99.6% |
SENSEX | 1.7% |
1.1% |
21.3% |
You may also like the below Video Courses